ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Insulet Corporation (PODD) stock declined over -4.49%, trading at $245.26 on NASDAQ, down from the previous close of $256.80. The stock opened at $250.62, fluctuating between $236.77 and $250.62 in the recent session.
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Employees | 3900 |
Beta | 1.29 |
Sales or Revenue | $1.70B |
5Y Sales Change% | 1.54% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Medical - Devices |